project id: TCGA-PAAD; case submitter id: TCGA-FB-A5VM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.06; rna integrity number: 7.7; age at index: 74; days to birth: -27362; days to death: 498; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1938; age at diagnosis: 27362; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 449.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; cigarettes per day: 1.3150684931506849; pack years smoked: 24.0; years smoked: 47.0; is ffpe: false; composition: Not Reported; days to collection: 91; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-FB-A5VM-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 65.0;